Evaluating the predictive value of biomarkers for efficacy outcomes in response to pertuzumab- and trastuzumab-based therapy: an exploratory analysis of the TRYPHAENA study

INTRODUCTION: Molecular markers that predict responses to particular therapies are invaluable for optimization of patient treatment. The TRYPHAENA study showed that pertuzumab and trastuzumab with chemotherapy was an efficacious and tolerable combination for patients with human epidermal growth fact...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Cancer Res
Main Authors: Schneeweiss, Andreas, Chia, Stephen, Hegg, Roberto, Tausch, Christoph, Deb, Rahul, Ratnayake, Jayantha, McNally, Virginia, Ross, Graham, Kiermaier, Astrid, Cortés, Javier
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4226982/
https://ncbi.nlm.nih.gov/pubmed/25005255
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr3690
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados